Global Laparoscopy Devices Market Extends at a Healthy CAGR of 7% by 2031

Introduction

Laparoscopy is a minimally invasive surgical technique that aids in diagnosing various abdominal and pelvic conditions, including cysts, adhesions, fibroids, and infections of the female reproductive system. Laparoscopy, known as "keyhole" surgery, is performed through a tiny incision. With a small incision in the abdomen, laparoscopes are placed to record images of abdominal organs. This process also facilitates tissue biopsies and surgical procedures, such as cholecystectomy (laparoscopic gallbladder surgery), appendectomies (appendix removal), and anti-reflux surgery, treatment for acid reflux, often known as GERD (gastroesophageal reflux disease). Laparoscopy devices are widely utilized in various surgical procedures because they have improved the precision of surgical operations.

Market Dynamics

Growth in Preference for Minimally Invasive Procedures Drives the Global Market

In recent years, as the demand for minimally invasive operations has increased, the preference for laparoscopic procedures has increased substantially. Most patients resist open surgical treatments, which boosts the need for "keyhole" procedures. Minimally invasive surgical methods provide patients with desirable benefits, such as quicker recovery, less surgical invasion, and less post-operative pain. In addition, minimally invasive procedures are utilized in various medical settings, including hospitals and clinics. This is due to the cost-effective solutions and high precision such surgeries offer. Patients worldwide accept minimally invasive procedures since there is less post-operative trauma. Also, these procedures give the same therapeutic benefits as those available operations. In addition, the usage of laparoscopic equipment in aesthetic treatments has increased in recent years. The demand for minimally invasive surgeries in industrialized nations like the United States and Canada also adds to the expansion of the industry.

Growth in the Adoption of Robot-Assisted Laparoscopy Devices Creates Tremendous Opportunities 

Traditional laparoscopes' shortcomings are overcome with the assistance of robot-assisted laparoscopes. The development of these technologies intends to assist surgeons in providing better patient care. In addition, robot-assisted laparoscopy offers all of the advantages of minimally invasive treatments, including reduced post-operative pain, a shorter hospital stay, a shorter recovery period, and a quicker return to work. The U.S. Food and Drug Administration (FDA) has cleared the da Vinci robot for gynecological surgery. Robot-assisted laparoscopes are gaining popularity in procedures involving radical prostatectomy, partial nephrectomy, and gynecology. Reducing the overall cost of robot-assisted laparoscopes and the cost of maintenance is anticipated to present lucrative opportunities in the coming years.

Regional Analysis

North America held the largest market share and is anticipated to grow at a CAGR of 5.5% during the forecast period. As North America is recognized for its healthcare facilities and medical services, technologically improved laparoscopic instruments are adopted more rapidly in the region. The acceptance rate for laparoscopic equipment is increasing because of the development of unique 3D and 4D cameras for viewing, miniaturized devices, and direct energy systems. In addition, the increase in occurrences of morbid obesity in North America is the primary reason driving the market growth for laparoscopic devices. As the prevalence of morbid obesity has increased among Americans, there will undoubtedly be a more significant need for weight-loss surgeries in the region, stimulating the development of laparoscopy equipment. In addition, robotic technology has improved the precision of laparoscopic devices, generating numerous chances for the North American laparoscopy devices market.

Europe is anticipated to grow at a CAGR of 4.6% during the forecast period. Several medical device business pioneers in laparoscopy and medical imaging are based in Europe and renowned for their superior medical services and healthcare facilities. B. Braun Melsungen AG and Henke-Sass Wolf GmbH are two enterprises in the region that specialize in laparoscopic devices. Europe has implemented a hospital reimbursement system known as DRG-based hospital payment. It allows hospitals to modernize their equipment with cost-effective and clinically efficient technologies. Laparoscopy devices have continued to grow in the region despite the slow recovery from the European financial crisis. Great Britain, France, and Germany dominate the European laparoscopy devices market. The market for laparoscopy devices is expanding in Germany, Austria, and Switzerland due to rising demand for innovative and cost-effective surgical solutions.

Key Highlights

• The global laparoscopy devices market size was valued at USD 6.96 billion in 2022. It is estimated to reach USD 12.80 billion by 2031, growing at a CAGR of 7% during the forecast period (2023–2031).
•  Based on product type, the global laparoscopy devices market is divided into laparoscopes, energy devices, insufflators, robot-assisted surgical systems, suction or irrigation system, closure devices, hand instruments, access devices, accessories, and others. The energy devices segment is responsible for the largest market share and is anticipated to grow at a CAGR of 5.7% throughout the forecast period. 
• Based on application, the global laparoscopy devices market is segmented into general, bariatric, gynecological, urological, colorectal, and others. The general surgery segment owns the market and is expected to exhibit a CAGR of 4.7% during the forecast period. 
• Based on end-user, the global laparoscopy devices market is segmented into hospitals, clinics, and others. The hospital segment dominates the market and is estimated to exhibit a CAGR of 5.3% during the forecast period.
• North America held the largest market share and is anticipated to exhibit a CAGR of 5.5% during the forecast period. 

Competitive Players

1. B. Braun Melsungen AG
2. ConMed Corporation
3. Boston Scientific Corporation
4. Johnson and Johnson
5. Medtronic Plc. (Covidien)
6. Karl Storz SE and CO. KG
7. Richard Wolf GmbH
8. Olympus Corporation
9. Stryker Corporation

Recent Developments

Recent Developments

• March 2023- Ronovo Surgical recently invited prominent gynecological and urology surgeons to assess the performance of its recently announced CarinaTM RAS Platform, the first Chinese robotic-assisted surgery (RAS) platform built for laparoscopic procedures.
• February 2023- TELA Bio announced the U.S. commercial launch of two novel OviTex® LPR device configurations for robotic and laparoscopic repair of massive abdominal hernias.

Segmentation

1. By Product Type
   1. Laparoscopes
   2. Energy Devices
   3. Insufflators
   4. Robot-Assisted Surgery Systems
   5. Suction or Irrigation Systems
   6. Closure Devices
   7. Hand Instruments
   8. Access Devices
   9. Accessories
   10. Others
2. By Applications
   1. General Surgery
   2. Bariatric Surgery
   3. Gynecological Surgery
   4. Urological Surgery
   5. Colorectal Surgery
   6. Others
3. By End-User
   1. Hospitals 
   2. Clinics
   3. Others